TECH health company ResApp, which holds the exclusive license to develop an app based on technology funded by Bill and Melinda Gates, has enjoyed a solid re-entry to the Australian share market.
RESAPP shares began trading at 2.3 cents at 1000 AEST after undertaking an oversubscribed public capital raising of $4 million.
By 1116 AEST, shares were worth 2.2 cents, a rise of 3.13 per cent on the two cent issue price. The company was re-listed after being acquired by Narhex Life Sciences in February.